Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial.

about

Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial.

Item

http://www.wikidata.org/entity/Q47773596

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ulipristal Acetate and Extrace ...... ized Placebo Controlled Trial.

@en

Ulipristal Acetate and Extrace ...... ized Placebo Controlled Trial.

@nl

type

Item

label

Ulipristal Acetate and Extrace ...... ized Placebo Controlled Trial.

@en

Ulipristal Acetate and Extrace ...... ized Placebo Controlled Trial.

@nl

prefLabel

Ulipristal Acetate and Extrace ...... ized Placebo Controlled Trial.

@en

Ulipristal Acetate and Extrace ...... ized Placebo Controlled Trial.

@nl

P1476

Ulipristal Acetate and Extrace ...... ized Placebo Controlled Trial.

@en

P2093

Jeris Cox

http://www.w3.org/2001/XMLSchema#string

Joy Britten

http://www.w3.org/2001/XMLSchema#string

Minnie Malik

http://www.w3.org/2001/XMLSchema#string

Terrence Lewis

http://www.w3.org/2001/XMLSchema#string

William H Catherino

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study

Activating transcription factor 3 gene expression suggests that tissue stress plays a role in leiomyoma development

Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis

CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial

Mechanism of Action of Ulipristal Acetate for Emergency Contraception: A Systematic Review

Diverse functions of matrix metalloproteinases during fibrosis

Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis

Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety

Management of uterine leiomyomata: what do we really know?

Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas.

P304

198-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1933719117728802

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28929861

http://www.w3.org/2001/XMLSchema#string

P921

placebo

P932

5933104

http://www.w3.org/2001/XMLSchema#string